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Layered double hydroxide-based nanocomposite
scaffolds in tissue engineering applications
Burcin Izbudak,†a Berivan Cecen,†bcd Ingrid Anaya,†e Amir K. Miri,bc Ayca Bal-
Ozturk *af and Erdal Karaoz*agh
Layered double hydroxides (LDHs), when incorporated into biomaterials, provide a tunable composition,
controllable particle size, anion exchange capacity, pH-sensitive solubility, high-drug loading efficiency,
efficient gene and drug delivery, controlled release and effective intracellular uptake, natural
biodegradability in an acidic medium, and negligible toxicity. In this review, we study potential
applications of LDH-based nanocomposite scaffolds for tissue engineering. We address how LDHs
provide new solutions for nanostructure stability and enhance in vivo studies' success.
1. Introduction
With the development of nanotechnology, biomaterials with
nanoscale features have been commonly designed to be used in
drug delivery and articial matrices.1 The potential of various
nanomaterials, such as carbon nanotubes,2,3 graphene oxide
nanosheets4,5 and nanoclays, (i.e. halloysite nanotubes and
kaolinite nanosheets)6–8 has been extensively investigated.
Among numerous nanomaterials, LDH nanoparticles, nano-
sized inorganic clay, have attracted the enormous attention of
researchers worldwide due to their advantages, such as
biocompatibility, antigenicity, acceleration of the tissue regen-
eration, biodegradability, bioactive interface, and controlled
release of drugs. LDHs is a commonly used nanomaterial in
nanomedicine and bioengineering with a unique 2D structure,
controllable particle size,9 and anion exchange capacity,10 pH-
sensitive solubility, thermal stability,11 chemical stability,12
high-drug loading efficiency,13 efficient drug delivery,14 low
toxicity,15 and biocompatibility properties.16 LDHs are 2D
hydrotalcite compounds having width sizes less than 100 nm,
and their anionic exchange capacity and organic/inorganic
intercalations make them great carriers for drugs and biolog-
ical agents.17 As a storage matrix, the release of different anionic
species into the structure can be controlled by acidic pH.18 They




where divalent cations (M2+) are Mg2+, Fe2+, or Co2+; trivalent
cations (M3+) are Al3+, Fe3+, or Gd3+; and non-framework and
exchangeable anions (An) are Cl, CO3
2, NO3
, etc.19 LDHs
have a layered crystal structure and consist of a positively
charged host layer, since M3+ partially replaces M2+ anions,
alternating with interlayers containing exchangeable anions
hydrated with water molecules19,20 (Fig. 1A). The LDHs'
synthesis methods are co-precipitation, ion exchange in solu-
tion, sol–gel, hydrothermal, urea hydrolysis, and the
reconstruction/rehydration method (i.e., memory-impact
method).19,21 The co-precipitation method is the simplest one,
in which basic solutions of LDHs can be easily prepared in high
purity and crystallinity.21,22 The rich-OH ionic groups and
natural positive charges in the structure enable the formation of
3D nano-hybrid structures through interactions with molecules
and nanomaterials. Surface modication can customize for
core, shell, dot-coated, and targeting in the carrier system.23
Different characterization methods were used to study LDHs
with biological components, as shown in Fig. 1B and C.15,24 The
three main groups of LDHs used in biomedical applications are
(I) organic agents entrapped between the interlayer of LDHs, (II)
the dispersion of LDHs into a polymeric network, and (III) LDHs
intercalated with biological molecules.25 There have been
numerous studies on these three groups, such as bone tissue
engineering;26 however, there are limited tissue engineering
studies. Here, we introduced the potential applications of LDHs
in tissue engineering applications. We focus on biocompati-
bility, antibacterial properties, and osteogenic differentiation
associated with LDHs in tissue engineering, and we discuss
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fDepartment of Analytical Chemistry, Faculty of Pharmacy, Istinye University, Istanbul,
Turkey
gDepartment of Histology and Embryology, Faculty of Medicine, Istinye University
Istanbul, Turkey
hCenter for Regenerative Medicine and Stem Cell Research and Manufacturing
(LivMedCell), Istanbul, Turkey
† Equal contribution.
Cite this: RSC Adv., 2021, 11, 30237
Received 22nd May 2021
Accepted 31st August 2021
DOI: 10.1039/d1ra03978d
rsc.li/rsc-advances




































































































View Journal  | View Issue
current challenges and future perspectives. The manuscript is
divided into four sections. First, the bioactivity of LDHs in
different systems is discussed. Second, the efficiency of LDHs
for antibacterial properties is well explained for various cases.
Third, their applications in bone engineering are shown in
detail. Lastly, future trends and perspectives are discussed. In
this paper, we introduce the recent advances of LDHs for bone
and cartilage tissue-engineered scaffolds in regenerative medi-
cine as drug delivery carriers.
2. Bioactivity of LDHs
Hydrogels can be designed to mimic the extracellular matrix of
so tissues for delivery nanocarriers and cellular scaffold
applications in regenerative medicine. In most cases, they only
offer physical support, and they need to be biofunctionalized for
cell spreading, proliferation, and differentiation. The toxicity
levels for LDHs have been tested for various cellular compo-
nents (Table 1). These hydrogels' bioactivation involves the
copolymerization of acrylate functional peptides cross-linked
with poly(ethylene glycol) (PEG) derivatives. Huang et al.27
describe bioactive nanocomposite PEG hydrogel preparation
cross-linked by polydopamine-coated layered double hydrox-
ides (PD-LDHs). The PEG hydrogel with the catechol-rich PD-
LDH showed tunable mechanical strength, bioactivity and
bioadhesion, self-healing ability and supported the osteogenic
differentiation of human mesenchymal stem cells.
Bioadhesion is another critical consideration in designing
hydrogels for tissue regeneration. The hydrogels' tight adhesion
potentially leads to better integration with the surrounding
biological tissues, facilitating inltration of bioactive molecules
and cells promoting tissue healing.27 The cellular and
Fig. 1 (A) The general structure of LDHs. This figure is reproduced from ref. 19 with permission from Elsevier, copyright 2017. (B) The available
design of LDHs experiments. This figure is reproduced from ref. 15 with permission from John Wiley and Sons, copyright 2019. (C) Current
research on LDHs, and the existing category of LDH precursors, nanoparticles, hybrids, and biohybrid composites. This figure is reproduced from
ref. 24 with permission from John Wiley and Sons, copyright 2017.



































































































biochemical properties of LDHs were evaluated, in which two
combinations of LDHs (Mg–Al–Cl and Zn–Al–Cl) with different
concentrations were tested (Fig. 2A). Standard viability analysis
(MTT) was performed to assess the acceptable range of
concentrations. A range of 0.002–0.2 mg mL1 did not lead to
a half-maximal inhibitory concentration (IC50) value within
24 h. Mg–Al–Cl showed a better cell growth pathway for bro-
blast adhesion when compared to Zn–Al–Cl (Fig. 2B and C). The
effects of the culture media on the shape of LDHs were stated to
be negligible. The results indicate that LDHs guide cellular
adhesion, migration, proliferation and delineate new advances
on the biomaterial area implemented for so tissue bioengi-
neering.26 Baek et al. examined the cytotoxic effects of two
different types of LDHs, Mg–Al–CO3, and Mg–Al–Cl, on human
lung alveolar carcinoma epithelial cells (A549) and normal
human lung alveolar epithelial cells (L-132). They prepared
LDHs by the molar ratio of Mg/Al ¼ 2 using the co-precipitation
process. The production of reactive oxygen species (ROS) was
then determined with a cell permeable uorescent probe, 20,70-
dichlorouorescein diacetate (H2DCFDA). The human lung
alveolar carcinoma epithelial cells (A549) and normal human
lung alveolar epithelial cells (L-132) were treated with LDHs at
concentrations up to 1000 mg mL1 for 72 hours. The stability
and toxicity of LDHs were investigated for the effect of the
proliferation of L-132 and A549 cell lines. Mg–Al–CO3 LDHs
with a size of 200 nm led to signicant ROS in the A549 cell line.
Mg–Al–CO3 LDHs showed higher toxicity in comparison to Mg–
Al–Cl LDHs.28
Choi et al.29 evaluated the toxicity of anionic clay, layered
metal hydroxide nanoparticles, two human lung epithelial cells,
and carcinoma A549 normal L-132 cells. They determined it to
be low tested at the concentrations used (<250 mg mL1) within
48 h in comparison with other inorganic nanoparticles, such as
silica, iron oxide, and carbon nanotubes. Higher concentrations
(250–500 mgmL1) of LDHs for 72 h resulted in an inammatory
response with oxidative stress and membrane damage. There-
fore, oxidative stress can be caused depending on the type of
nanoparticle,30 concentration, and exposure time, affecting the
toxicity.
Peng et al. developed the different LDHs (Mg–Al, Mg–Fe, Zn–
Al, and Zn–Fe) to apply bone implants. They evaluated the
feasibility of the LDH with biological functional elements as
bone implants, M2+ was chosen for being essential for bone
regeneration, Zn2+ was selected for skeletal development and
antibacterial activity, while Al3+ and Fe3+ for their low toxicity.
Osteoblast-like cells (MC3T3-E1), related to bone growth, and
human umbilical endothelial cells (HUVECs) were investigated
to determine the cytotoxic activity LDHs. LDHs with specic
amounts in the form of extracts or suspensions were treated.
Mg–Al and Mg–Fe LDHs indicated higher cell viability than Zn–
Al and Zn–Fe LDHs. The concentrations of Zn–Al LDHs extract
higher than 1.11 mg mL1 led to signicant toxicity. The
apparent toxicity of Zn–Fe LDHs was observed at an extract
concentration of 123.5 mg mL1. Unlike the extract, Zn–Al and
Zn–Fe LDHs suspensions showed more severe toxicity to
HUVEC and MC3T3-E1 than Mg–Al Mg–Fe LDHs when the
Table 1 Toxicity data for LDHs with different cell cultures
LDH type/molar
ratio Size (nm) Conc. (mg mL1) Cell types Assay (test) Results Ref.
Mg–Al LDHs 2 : 1 50–100 40 Human embryonic
kidney cells (293T)
MTT The non-toxic effect, more
than 80% viability aer
three days
31
Zn–Al LDHs 2 : 1 — 5–150 Mouse broblast cells
(3T3)
MTT 90% viability at 100 mg
mL1 concentration
32
Mg–Al LDHs 3 : 1 80–90 20 Human cervical cancer MTT Very low toxicity aer 72 h
treatment
33
Mg–Al LDHs 4 : 1 — 50 Breast (MCF-7), HeLa,
and broblast (3T3)
cells
MTT Non-toxic effect 34
Mg–Al LDHs 3 : 1 — 40 GES-1, MKN45 and
SGC-7901 cells
MTT Non-toxic effect 35
Zn-LDHs — 25–0.195 Monkey kidney (Vero-3)
cells
MTT 92% viability at 25 mg mL1
concentration
36
Zn-LDHs — 5–500 mg kg1 Rat Oral toxicity Non-clinical toxicity and
animal demise at 5–500 mg
kg1 dose
37
Zn–Al LDHs 2 : 1 — 25–800 PC12 cells MTT Low toxic effect at 800 mg
mL1 concentration
38
Mg–Al LDHs 3 : 1 100 2–40 Mouse embryonic stem
cells (mESC)
MTT Excellent biocompatibility 39
Mg–Al LDHs 3 : 1 50, 100 10–400 Mouse embryonic stem
cells (mESC)
MTT No signicant cytotoxicity
at a concentration up to 40
mg mL1
40
Mg–Al LDHs 2 : 1 — 1–1000 Human leukemia cells
(HL-60)
MTT Non-toxic effect 41



































































































concentration of their breaks was higher than 41.2 mg mL1.42
The present study evaluated the mechanical properties, as well
as cytotoxicity and antibacterial ability. Zn–Fe LDHs is the most
suitable for a bone implant. It has the highest hardness and
elastic modulus; amismatch in the elastic modulus between the
bone and the implant would lead to stress shielding, which
causes bone resorption aer surgery.
One major issue of bone implants is the formation of
bacteria lms. Thus, it is essential to engineer the LDHs with
antibacterial potential to allow their osseointegration. It has
been reported in the literature that Zn damages the membrane
and nucleic acid and denatures the bacteria proteins and
enzymes. Therefore, bacteria (E.coli and S. aureus) showed lower
tolerance concentration of Zn–Al LDH and Zn–Fe LDH. Soo et al.
reported that Mg–Al and Zn–Al LDHs at concentrations up to
500 mg mL1 had no toxic effects within 48 hours in various cell
lines and red blood cells.
The ndings revealed that Zn–Al LDHs induced much more
serious membrane damage and hemolysis than Mg–Al LDHs.
Based on these ndings, Mg–Al LDHs in various sizes (50, 100,
200, 350 nm) were tested. Mg–Al LDHs at concentrations up to
500 mg mL1 were treated with A549 cells for 48 hours. While
Mg–Al LDHs of 50 nm in size treated with A549 cell lines were
found to be more toxic than larger nanoparticles, Mg–Al LDHs
in size range from 100 to 200 nm were found to show very low
cytotoxicity. Even LDHs of 50 nm in size, which is a toxic effect
in vitro, did not result in body weight loss or mortality in vivo.
On the other side, in in vivo studies, all LDHs groups did not
cause any mortality or weight loss of 600 mg kg1. The
assumption that LDHs are attractive biocompatible biomate-
rials for biological and medical applications has been
conrmed.43
Cunha et al. (2016) assessed the biocompatibility, bio-
integration, non-immunogenic feature, and antigenicity prop-
erties of Mg–Al and Zn–Al LDHs tablets post-implanting
intramuscularly in rat abdominal as it allows to test the acti-
vation of the whole immune response in few 7 days and the
rejection process by brous capsule formation in a more
extended period, 28 days through the microcirculation.44 A
stroboscopic LED video-microscopy was used to observe the
micro-circulation patterns of the host tissues around LDHs. The
two types of LDHs had 80–100 nm, and the co-precipitation
process produced them. The sterilized LDHs were implanted
in rats' abdominal walls, and the results showed that LDHs had
appropriate biocompatibility on day 7. Histological tests eval-
uated the reaction of the LDHs with host tissue post-
implantation neo-vascularized connective tissue was observed
around the treated area (Fig. 3). The real-time observation
showed that muscle tissues implanted with Mg–Al and Zn–Al
LDHs support non-immunogenic properties, adequate extra-
cellular matrix remodeling to the desired collagen type wound
healing according to the tablet biophysical composition. This
healing process involves the deposition of collagen and bro-
nectin bers; the Zn–Al LDH tablet sample exhibited
a predominance of collagen type-III bers. Besides, the alkaline
pH buffering behavior of the LDHs promoted normal cellular
response as chemotaxis, respiratory activity, and proliferative
capacity of leukocytes; thus, good tissue repair response. These
Fig. 2 (A) The LDHs structure. (B) The effect of two compositions and types of LDHs, Mg–AI–CI and Zn–Al–CI LDHs, on fibroblast adhesion. (C)
The cell morphologies on the LDHs constructs after 24 hours. This figure is reproduced from ref. 26 with permission from John Wiley and Sons,
copyright 2019.



































































































results suggest that they can be used in biomedical applications
for drug delivery.44
Nanocomposite-based hydrogels are enhancing the
mechanical and chemical properties of hydrogels and expand-
ing their biomedical applications. When encapsulated with
inorganic nanoparticles, they have shown excellent biocom-
patibility, stability, andmechanical properties compared to new
hydrogels due to the remarkable physical, chemical, and bio-
logical features of inorganic nanoparticles. Wang et al. mixed
LDHs and nanohydroxyapatite (HAp) to develop a porous
nanocomposite hydrogel made of poly(N-isopropyl acrylamide)
(PNIPAm/LDHs/HAp), which showed superior hemocompati-
bility, enhanced mechanical strength, and reversible swelling/
deswelling properties. These results support that the devel-
oped hydrogel embedded with LDHs and HAp has excellent
potential for tissue engineering and clinical practices.45
3. Antibacterial properties of LDHs
Antibacterial properties in scaffolds yield signicant success
and adaptation in clinical applications.46 The antimicrobial
activity of scaffolds allows controlling surgical infections and
reducing any antimicrobial agents' injection.47 An ideal implant
should have an antibacterial ability while providing cell
adhesion and proliferation. Metallic ions such as Ag, Zn, Ti, Sr
can be incorporated into scaffolds to accelerate tissue regener-
ation with minimal infections.48 These metallic ions cause ROS
production in antibiotic-resistant bacteria, causing membrane
and DNA damage and inactivating metabolic proteins such as
respiratory enzymes.49 LDHs can decrease the number of
nutrients in the culture media by adsorbing on the surface of
particles. Differences in the environment's physicochemical
features occur, inhibit bacteria's growth (Fig. 4A). In the
meantime, electrostatic interactions between the cationic LDHs
and negatively charged bacterial surface can cause bacterial
growth inhibition.50
LDHs also show strong ion-exchange potential and porous
structures; for example, Zn ion-based LDHs exhibit strong
antibacterial properties leading to bone implant's fast regen-
eration.51 Peng et al. have recently reported an alternative
method by preparing Mg–Al, Mg–Fe, Zn–AI, and Zn–Fe LDHs.
Extract and suspension forms of Zn–Al LDHs and Zn–Fe LDHs
displayed a better antibacterial impact on Gram-positive S.
aureus and Gram-negative E. coli compared to the Mg–Al and
Mg–Fe LDHs. Zn–AI and Zn–Fe LDHs into the scaffold showed
higher success and potential for the application of antibacterial
implants.42 The bacterial resistance to antibiotics increases over
time. Gohi et al. developed a new organic–inorganic hybrid
Fig. 3 Histological images of the implants after 28 days show the final tissue reconstruction and the persistence of the implanted LDHs
constructs. This figure is reproduced from ref. 44 with permission from Springer Nature, copyright 2016.



































































































biomaterial consisting of Zn–Al LDHs/chitosan (CS). With the
release of Zn2+ and Al3+ metal ions from Zn–Al LDHs/CS hybrid
biomaterial, an increase of the inhibition zone of 41.6% against
E. coli and almost 100% for Penicillium cyclopium (P. cyclopium)
was observed (Fig. 4B).52 In another study, an antibacterial
environmentally friendly polyurethane (WPU)-based composite
was synthesized with Zn–Al LDHs, and ZnO, ZnO LDHs have
been reported to inhibit bacteria growth and their proliferation
effectively. The antibacterial effect was assessed for composite
biomaterials against Gram-negative E. coli and Gram-positive S.
aureus. The results show that WPU embedded with ZnAl-LDHs/
ZnO has solid antibacterial potential. The antibacterial activity
Fig. 4 (A) A schematic illustration of an antibacterial-experimental strategy and possible antibacterial mechanism of LDHs. This figure is
reproduced from ref. 50 with permission from Elsevier, copyright 2020. (B) Effects of CS, Zn–Al LDHs, and CS/Zn–Al LDHs against P. cyclopium
and E. coli. This figure is reproduced from ref. 52 with permission from MDPI, copyright 2019.



































































































of WPU/Zn–Al LDHs/ZnO composite exists on two mechanisms.
First, ZnO activates intercellular ROS such as hydrogen peroxide
(H2O2) and strengthens oxidizing agents, damaging the bacte-
rial cells. Second, Zn+2 ions in LDHs penetrate the bacterial
membrane while altering the cell membrane's permeability and
causing individual proteins' denaturation.53 In another similar
study, the proliferation of S. cerevisiae, S. aureus, and E. coli has
been severely inhibited by Zn–Ti LDHs and evaluated the size-
dependent antibacterial behavior of Zn–Ti LDHs. Ti+3 cations
in Zn–Ti LDHs with a size of 40 nm showed a more active
antibacterial effect than metal oxide and TiO2. Zn–Ti LDHs
killed more than 95% of the bacteria and exhibited excellent
antibacterial action.54
Since silver has antibacterial properties, composite bioma-
terials have been preferred in many studies. Mehdi et al.
focused on the antibacterial effect of silver and LDHs in the
carboxy-methyl-cellulose (CMC)-based hydrogel. CMC nano-
composites' antibacterial effect includes Mg–Al, Ni–Al, Zn–Al,
and-Al LDHs against E. coli and S. aureus bacteria has been
investigated. Cu–Al LDHs/CMC and Zn–AI LDHs/CMC nano-
composites showed more antibacterial effects than nano-
composites, including Mg–Al Ni–Al LDHs. This is because of Cu
and Zn ions' antibacterial properties released fromCu–Al LDHs/
CMC and Zn–AI LDHs/CMC constructs. The inhibition zone for
Cu–Al LDHs/CMC and Zn–Al LDHs/CMC against E. coli
decreased aer 3 days. On the other hand, they displayed better
potential towards S. aureus and kept their antibacterial impact
for more than 2 weeks.55 Gabriela et al. reported the antibacte-
rial effects on Zn–AI LDH, Ag/Zn–AI LDHs, and AgNP against S.
aureus and E. coli. The superior stability and efficacy of the
antibacterial potential of Ag/Zn–AI LDHs are possibly owing to
the power of the LDHs structure to adsorb microorganisms;
thus, enabling strong interactions with the silver from the
surface.56
Ahmed et al. successfully used Zn for antibacterial properties
of polyaniline (PAn) nanocomposite, including Zn–Al LDHs.
The antimicrobial activity of PAn/Zn–Al LDHs nanocomposites
was assessed against Gram-positive (Staphylococcus aureus),
Gram-negative (Pseudomonas aeruginosa) bacteria, and fungi
(Candida albicans). The results reported that PAn/Zn–Al LDHs
prevented bacteria and fungi from stuck on the surface and
provided antimicrobial effects by growing the ability.57 In
another study, Penicillin G (PNG)-loaded Zn–Al LDHs prepared
to make prolonged antibacterial potential against E. coli. In the
meantime, the released Zn+2 ions from Zn–Al LDHs had an
antibacterial ability by signicantly improving the antibacterial
effect of PNG.58
Jin et al. intercalated an anticancer drug 5-uorouracil/
cyclodextrin (5-FU/CMCD) into a Zn–Al LDH. The drug release
time was prolonged and controlled by the hydrophobic envi-
ronment of the CMCD cavity and by the durability of the LDH.
Therefore, the release behavior of 5-FU from 5-FU/CMCD-LDH
composite could be modulated by a change in the environ-
mental pH value.1 Other pharmaceutical compounds such as
ibuprofen, fenbufen, and diclofenac have been incorporated




The bone tissue that forms the skeletal system is protected and
renewed by the proliferation of osteoblasts and osteoclasts. The
primary cells that provide bone formation are osteoblasts,
which allow the shaping of new bone tissue and mineralization
with ECM. Throughout different experiments, embryonic stem
cells (ESCs), pluripotent stem cells (PSCs), MSCs, and bone
marrow (BM-MSCs) are commonly used to differentiate into
osteoblasts.47 Genes that provide osteogenic differentiation
have many transcription factors and proteins. The primary
transcription factor is runt-related transcription factor 2
(RUNX2), which provides the expression of osteocalcin (OCN),
collagen type 1 (COL1A1), and osteocalcin (OCN) proteins.59
Another specic transcription factor is alkaline phosphatase
(ALP), which measures osteoblasts' ability to mature and
regenerate bone.60 Tissue engineering creates scaffolds that can
regenerate bone by stimulating genes, mimicking the bone
structure, and providing osteogenesis.61 Due to its ionic content
and layered structure, LDHs have been recently preferred in
bone scaffolds reducing mechanical strength, producing Mg+2,
and forming an alkaline micro-environment (Table 2).62 During
Mg+2 ions released from LDHs, osteogenic cells' integrin
expression is upregulated,63 and Mg+2 ions have a synergistic
effect on stem cells' ALP activity and osteogenesis pathways.64
During osteoclastogenesis, LDHs promote osteoblastic pheno-
type by up-regulating osteogenic marker genes, RANKL and
OPG. The pathways of signaling in response to LDHs are actu-
alized by osteoblasts.61 In conclusion, LDHs can be considered
a signicant stimulus during osteoclastogenesis and preferred
to repair bone defects.
The microstructure and chemical composition of gelatin/
LDHs/Hap-based scaffolds were similar to native bone struc-
tures. The gelatin/LDHs/HAp-based scaffold's bone regenera-
tion ability was shown in orthopedic and regenerative surgery
for bone healing.65 For signicant bone defects to restore
healthy bone, engineered scaffolds should be biocompatible
and support osteogenic differentiation without causing infec-
tion. Dandan et al. successfully prepared a new nanocomposite
scaffold by combining Ag-laden MgSrFe LDHs with CS (CS/Ag-
MgSrFe LDH). CS/Ag-MgSrFe nanocomposite scaffold was
non-toxic on human bone marrow-derived mesenchymal stem
cells (hBMSCs). The cells showed enhanced spread, prolifera-
tion, and adhesion on the scaffold. Due to the release of Sr2+
ions from LDHs, ALP RUNX2 and BMP-2 expression increased.
CS/Mg–Fe LDHs were compared with CS/Ag-MgSrFe LDH
nanocomposite scaffold, and data indicated that the nano-
composite scaffolds containing Ag and Sr elements support
osteogenic differentiation. Besides, Ag components in LDHs
provided excellent bone formation, which gained antibacterial
activity and kept osteoinductivity (Fig. 5C).66
Heqin et al. utilized a new nanocomposite consisting of PEG-
based hydrogel by using polydopamine-coated LDHs (PD-
LDHs). The catechol-rich PD-LDHs nanosheets not only
possessed strong bioadhesive properties in the aqueous



































































































environments but also increased the mechanical strength of the
obtained PEG-based hydrogel (Fig. 5A and B). It was seen that
PD-LDHs cross-linked PEG-based nanocomposite hydrogel
enhanced adhesion, spreading, and osteogenic differentiation
of human derived mesenchymal stem cells (hMSCs). As a result,
they carried out a nanocomposite hydrogel that can have
incredible potency in regenerative medicine and open up a new
way to design PEG-based nanocomposite constructs.67
Loredana et al. have explored the fundamental effects of
uoride ion-doped Mg–Al LDHs into hydrogel scaffolds.
Bisphenol-A glycidyl dimethacrylate (Bis-GMA) and tri-ethylene
glycol dimethacrylate (TEGDMA) combined with Mg–Al–F LDH.
The addition of Mg–Al–F LDHs promoted the mechanical
features of the hydrogel resin. Slow uoride release from
hydrogel increased human dental pulp stem cells (hDPSCs) and
ALP activity, an early odontoblastic differentiation for 28 days.
Considering these results, Mg–Al–F LDHs can be used as
a dental ller for tooth resins.68 In another study, Michelle et al.
developed a guided tissue regeneration membrane suitable for
periodontology. The controlled release of drugs was achieved
from tetracycline and alendronate from Mg–Al LDHs into the
poly(lactic-co-glycolic acid) (PLGA)-based membranes. Calvarial
osteoblasts isolated frommice were incubated with membranes
for ve weeks. A high ALP potential and bone nodule formation
were detected, and Mg-AI LDHs supported anti-inammatory
and osteogenic activity as a bone gra.69
Tan et al. have designed a biomaterial to capture implant
failures to investigate antibacterial and osteogenic activities on
the different alkaline microenvironment of titanium surface-
associated with Mg–Al LDHs. Cellular adhesion, proliferation,
and ALP activities were examined on rat bone marrow mesen-
chymal stem cells (rBMSCs) and mouse osteoblast cells
(MC3T3-E1) 1,4 and 7 days. They also conrmed that Mg-AI
LDHs and titanium's alkaline environment regulates the
Table 2 LDHs major applications for bone regeneration and tissue engineering
LDH type Application Cell line/tissue model Results Ref.
Mg–Al, Mg–Fe, ZN–Al,
and Zn–Fe LDHs
Bone implantation MC3T3-E1 Zn–Fe had the highest hardness and
elastic modulus, most suitable avoiding
bone resorption aer surgery.
42
Mg–Fe LDH Bone implantation rBMSCs Mg–Fe LDH lms on titanium increased
the ALP activity, collagen secretion, ECM





Bone regeneration hBMSCs ALP, RUNX2 and BMP-2 expression
increased. Ag and Sr elements supported
osteogenic differentiation and bone
formation.
66
PD-LDHs Bone regeneration hMSCs Increased the mechanical strength,
bioadhesion, spreading and osteogenic
differentiation of hMSCs.
67
Mg–Al LDHs Bone regeneration rBMSCs and MC3T3-E1 Mg–Al LDHs and titanium's alkaline
environment regulated the oxidative
stress, proliferation, and ALP activities of
osteoblast cells.
63
CS/Mg–Al LDHs/PFT-a Bone regeneration hBMSCs PFT-a induced the GSK3-b/y-cantenin
pathway and showed an enhancing effect
on hBMSC differentiation.
71
Mg–Al and Zn–Al LDHs Bone regeneration Preosteoblasts Enhanced osteocalcin (OCN), RUNX2,




Vitamin D3 (VD3) LDH-
Hap
Bone regeneration HAp containing
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Fig. 5 (A) Schematic illustration of polydopamine coating on LDHs and nanocomposite scaffold prepared by using 4-arm thiol-terminated
polyethylene glycol (4-arm PEG-SH) and polydopamine-coated LDHs (PD-LDHs), which can carry biomacromolecules and act as the sealant for
bone fracture. (B) The prepared nanocomposite scaffold has a strong sealant function for fractured bone pieces. This figure is reproduced from
ref. 67 with permission from John Wiley and Sons, copyright 2016. (C) Alizarin Red staining for ECM mineralization of hBMSCs with CS/Mg–Fe,
CS/Ag–MgFe/, CS/MgSrFe, and CS/Ag-MgSrFe scaffolds. This figure is reproduced from ref. 66 with permission from John Wiley and Sons,
copyright 2017. (D) The cranial defect was created, and CS/LDHs-PFTa or CS/LDHs constructs were placed in the cranial defects. (E) After twelve
weeks, the defect region was examined using reconstructing micro-CT images. This figure is reproduced from ref. 71 with permission from RSC
Pub, copyright 2017.



































































































Fig. 6 (A) In vivo implantation of gelatin/LDHs/HAp-based scaffold for bone tissue engineering application. This figure is reproduced from ref. 17
with permission from Elsevier, copyright 2017. (B) Schematic hGH loading in LDHs, and nanocomposite hydrogels. This figure is reproduced from
ref. 74 with permission from RSC Pub, copyright 2015. (C) Schematic representation of Ado-loaded Mg–Fe LDHs preparation and their appli-
cations. The developed nanoparticular platform synergistically induces the osteogenic differentiation of stem cells for healing of extended bone
defects by co-delivering the Ado ligand and ligation stimulator (Mg ion). This figure is reproduced from ref. 64 with permission from Elsevier,
copyright 2017.



































































































oxidative stress, proliferation, and ALP activities of osteoblast
cells.63 In another study, Qianwen et al. produced Mg–Fe LDH
lms on titanium surfaces for challenging tissue implantation.
Biocompatibility, proliferation, and osteoblast differentiation
of the lms were investigated on rBMSCs. They noticed that
Mg–Fe LDH lms on titanium increased the proliferation and
osteogenic differentiation, ALP activity, collagen secretion, and
ECM mineralization of rBMSCs, representing the encouraged
applications as hard tissue implant materials.70
p53 has a key rol in bone formation and metabolism.
Scientists have recently reported that decreased p53 function is
associated with bone formation. Pithrin-a (PFT-a) is a chem-
ical inhibitor of p53 that prohibits p53 role for bone forma-
tion.72 Yi-Xuan et al. investigated the different doses of PFT-a on
the CS/Mg–Al LDHs composite scaffolds (CS/Mg–Al LDHs/PFT-
a) hBMSCs. They claimed that CS/Mg–Al LDHs/PFT-a scaffolds
could be a novel strategy with natural bone regeneration func-
tionality. For all that, they emphasized the increased COL1, b-
catenin, and p53 by inducing the GSK3b/y-catenin pathway due
to the release of PFT-a. Consequently, PFT-a induced theWnt/b-
catenin pathway and showed an enhancing effect on hBMSC
differentiation (Fig. 5D and E).71 In another study, themolecular
mechanisms of Mg–Al and Zn–Al LDHs from preosteoblast to
mature osteoblast led to enhanced osteocalcin (OCN), RUNX2,
and Osterix (OSX). Mg–Al LDHs have a keynote regulation on
OSX mRNA levels reprogramming the mineralization and
osteoclast-osteoblast fusion balance with signal molecules.61
Fateme et al. investigated the encapsulation of vitamin D3 on
the gelatin-based scaffolds. LDH-HAp was combined with
vitamin D3 to reinforce scaffolds. They observed that vitamin
D3 plays a primary function in calcium accumulation, ALP
activity regulation and osteoblastic expression. Reinforcement
with vitamin D3 (VD3) the LDH-HAp into the scaffolds
increased the mechanical strength and ossication, mimicking
the mineral/organic structure of the natural bone and VD3
signaling effect. The HAp containing scaffolds (LHG and LHGD)
avoided the adverse impacts of burst release, showed less water
uptake, and recrystallized HAp, resulting in more bioactivity in
these scaffolds. The more packed structures of LGD and LHGD
lead to a decrease in the degradation rate due to less diffusion.73
Narendra et al. have prepared nano-bio hybrid injectable
scaffolds (PAEU/LDH/hGH) to reduce the adverse effects of
human growth hormone (hGH) inhibited by their early degra-
dation short half-life. hGH was intercalated in the positively
charged Mg–Al LDHs through an anion exchange technique
(Fig. 6B). The injectable nano-biohybrid scaffold showed the
delayed-hGH release diffusion by dual-ionic interactions as the
scaffolds' pH and temperature sensitivity. Cytotoxicity using
HCT-166 cell lines and in vivo rat model was used to study the
scaffolds' biological response.74
Injectable hydrogels loaded with LDHs-hGH may be used
effectively for sustained-hGH delivery to enhance biological
efficaciousness and patient compliance.74 Adenosine (Ado)-
loaded Mg–Fe LDHs were also embedded within the inject-
able hydrogel to support the bone defect healing (Fig. 6C). The
dual delivery of Ado and Mg ions from Ado-loaded Mg–Fe LDHs
containing injectable hydrogel supported osteogenic
differentiation of stem cells through the synergistic activation
of the adenosine A2b receptor was indicated. Furthermore, the
injectable hydrogel promoted repairing rat tibia bone defects
aer six weeks. The serum hGH concentration remained high
(1 ng mL1) with the LDH-hGH complex and pristine PAEU-
hGH hydrogel for 1 and 3 days respectively, with a minimal
initial burst release compared with hGH alone; these effects are
mainly attributed to the formation of ionic complexes between
the anionic hGH and cationic PAEU hydrogels and the smaller
interconnected pores in the hydrogel.75
5. LDHs scaffolds in soft tissue
engineering
LDHs are biocompatible inorganic biomaterials that have
enhanced thermal stability and mechanical strength of the
scaffolds. Monika et al. fabricated LDH-PVC nanocomposite
scaffolds seeded by C3H10t1/2 cells. The hemolysis test showed
a positive effect and more blood compatibility on LDHs-
functionalized PVC scaffolds than the PVC scaffolds.75 Lee
et al. developed a new LDHs/polypeptide thermogel-based
nanocomposite system (Fig. 7). RGD-coated LDHs and car-
togen (KGN) in poly(ethylene glycol)-poly(L-alanine)-poly(L-
aspartate) (PEG-PA-PD) triblock copolymer, network were used.
This combination with tonsil-derived mesenchymal stem cells
(TMSCs) was proposed as an injectable scaffold for chondro-
genic differentiation. TMSCs in PAG-PA-PD scaffold with Mg–Al
LDHs retained a signicant increase in mRNA and protein
levels of type II collagen and SOX9.76
Giriprasath et al. developed a novel double-layer scaffold
made of HAp pellets coated by poly(3-hydroxybutyric acid)-
poly(N-vinylpyrrolidone) matrix and LDHs (HAp: NFM-LDHs).
The nanobrous bone gra's in vitro biocompatibility, and
Fig. 7 2D/3D nanocomposite platform incorporating stem cells,
kartogenin (KGN), and RGD-coated LDHs in a poly(ethylene glycol)-
poly(L-alanine)-poly(L-aspartate) (PEG-PA-PD) triblock copolymer
thermogel for effective chondrogenic differentiation of the stem cells.
This figure is reproduced from ref. 76 with permission from American
Chemical Society, copyright 2017.



































































































uorescent activity were examined for 1, 3, 7, and 14 days. MG63
cells showed outstanding cell adhesion and proliferation on
both the top and bottom layers of the scaffolds. The nano-
brous matrix resulted in signicantly higher cell adhesion
from day 3 to 14. Compared to the control of LDHs in the
structure, cell adhesion increased signicantly on HAp: NFM-
LDHs surface. This approach provides the opportunity to
perform alternative nanobrous bone gras containing Mg–Al
LDHs for bone tissue engineering applications.77 Hsiao et al.
indicated the possibility that an injectable and thermores-
ponsive hydrogel would be suitable for gene therapy by using
osteoarthritic chondrocytes. They formulated poly(N-iso-
propylacrylamide) (pNIPAAM) hydrogels with Mg–Al or Mg–Fe
LDHs by encapsulating siRNA and providing 80–95% siRNA
transfection in PNIPAAM/LDHs hybrid hydrogels. Expressions
of ACAN, MMP13, Col2A1 genes have been observed. Hydrogels
in blend with LDHsmay be good candidates specifying both cell
delivery and siRNA transfection.78
Seyedeh et al. have created a new ber-based biomaterial
that can mimic ECM in tissue organ development and regen-
eration. They combined samples with Mg–Al LDHs ranging
from 0.1 wt% to 10 wt% in in vitro experiments with stem cells
derived from mouse adipose (mADSCs). They also assessed the
effects of mADSCs on adhesion, proliferation, and viability, and
adipogenic differentiation throughout PCL enrichment with
Mg–Al LDHs. The composite electrospun PCL scaffolds had
a better cell adhesion and proliferation compared to non-
treated PCL. Additionally, a substantial increase in the adipo-
genic differentiation of mADSCs was obtained. The PCL-LDHs
scaffolds with high porosity (94%) indicated numerous possi-
bilities in applying so tissue engineering.79
Due to the complication of the corneal stroma ultrastructure,
efficient ECM production is exceptionally challenging. Mojgan
et al. have created a new poly(urethane-urea) (PUU) based
scaffold that can be used in corneal tissue engineering. Zn–Al
LDHs were synthesized using the co-precipitation method,
laden with vitamin C (VC), and dispersed in the PUU to control
VC release. The scaffolds were prepared with electrospinning to
mimic the corneal stroma. VC-loaded Zn–Al LDHs allowed the
adhesion of the corneal regeneration. According to the in vitro
effects of three types of experimental groups (PUU, PUU/Zn–Al
LDHs, and PUU/VC/Zn–Al LDHs), stromal keratocyte cells
exhibited some level of proliferation on the scaffolds through
the peak value obtained with PUU/VC/Zn–Al LDHs scaffolds
aer one week. The results showed signicant differences in
gene expression. A specic increase was observed in the
expression of ALDH3A1 protein, the keratocyte marker, and the
expression of ACTA2 gene a-SMA protein of the myobroblast
phenotype, the sustained release of VC from PUU/VC/Zn–Al
LDHs scaffolds. All results suggest that PUU/VC/Zn–Al LDHs
scaffolds may be ideal for corneal stromal tissue engineering.80
6. Future trends and perspectives
LDHs are successful candidates for carrying therapeutic agents
due to their high anion exchange capacities and charge densi-
ties for next-generation tissue engineering applications. The
advantages such as biocompatibility, biodegradability,
tunability, and high loading efficiency of LDH-based drug
carriers make this eld of study a high priority range and its
expansion to other biomedical applications. LDHs contribute to
drug release mechanisms via a pH-sensitive response, well-
regulated particle size, and interlayer spaces. They promise to
overcome low bioavailability, improve the thermal and photo-
stability, and sustain and control the release of the active drug,
thereby improving their pharmacokinetics and pharmacody-
namics. By increasing the effectiveness of the drug, they could
reduce the dose of administration as well as reducing the side
effects of current pharmaceutical drugs.
Stimuli-responsive nanomaterials have been developed for
delivering the drug to tumors. In the tumor hypoxic environ-
ment LDHs react with H2O2, this leads to a change in their
structure and then the release of the drug improving the ther-
apeutic efficacy. In the future, LDHs enhanced with nano-
particles could potentially be used in a lower pH medium for
faster and accurate tumor target drug delivery. Despite the
increase of LDHs applications in cancer research, it is still
required to understand LDHs and cells' interaction mecha-
nisms fully. Further studies are required for understanding the
activation of the intracellular pathways of the cancer cells and
tumor cell apoptosis with the help of the LDHs. Moreover,
proteins and antigens could be delivered by LDH nano-vaccines
for cancer immunotherapy and to enhance the immune system
overall. Another major highlight of the LDHs is their efficacy in
delivering genes to the target site. They have been shown
capable of transporting DNA and RNA avoiding non-specic
sites, some authors suggest that LDHs could be used for
transfection methods. Also, organic molecules such as
hormones and vitamins can be loaded into the LDHs for
controlled release.
Many challenges still exist for LDHs to evolve as a drug
delivery system of choice. While the thermosensitive LDHs can
be used for anti-HIV drug delivery in the vagina tract, the
positively charged LDHs can be a strategy for ocular drug
delivery, and its pH-dependent degradation can be a better
approach for tumor-targeted drug delivery; the sensitivity of
LDHs in an acidic environment is a hurdle in oral drug delivery
due to the enzymatic and acidic degradation in the stomach and
less absorption from the small intestine, this could be pre-
vented by using polymer coating or other encapsulation
methods. Moreover, when administered via the blood system
they may interact with negatively charge biomolecules in the
environment that may lead to loss of surface charge, aggrega-
tion, and precipitation, thus, improvement of the LDHs stability
is a major challenge. Despite the advances in the modication
or functionalization of the surface of the LDHs for major
stability, there are a few reports in drug delivery applications.
Further studies are required to understand the in vivo biode-
gradability and clearance of LDHs nanomaterials and to include
development of ultra-thin LDH nanosheets to avoid pre-mature
therapeutic agents release and controlled drug release.
LDHs have been used as composites for regenerative medi-
cine and tissue engineering applications. Herewith, LDHs can
create a bio-safe environment around cells and tissue surfaces.



































































































It is expected that tissue scaffolds should bemimicked like ECM
for cell adhesion, intercellular interaction, and cell differentia-
tion during tissue repairing. The absence of infection is
essential to accelerate the tissue regeneration in these tissue
implants. Thus, the scaffolds' mechanical properties can be
tuned by using LDHs to obtain a favorable environment as
successful implants with the antibacterial properties of LDHs.
Moreover, in bone therapy and regeneration, the release of Mg+2
ions from Mg–Al LDHs, provides an alkaline environment
formation and activation of osteogenic differentiation path-
ways. Furthermore, Mg–Al LDHs can also induce ALP activation
of osteoblasts. In the future, to develop the best commerciali-
zation for LDHs-based biomaterials in clinic, it is necessary to
improve the surface modication, the drug loading, and the
synthesis methods to produce highly stable and uniform LHDs
with minimal variation in size, geometry, and thickness.
Conflicts of interest
There are no conicts to declare.
Acknowledgements
The Scientic and Technological Research Council of Turkey
(TUBITAK) (Grant number 118S549) supported this work.
References
1 M. Goldberg, R. Langer and X. Jia, Nanostructured materials
for applications in drug delivery and tissue engineering, J.
Biomater. Sci., Polym. Ed., 2007, 18, 241–268, DOI: 10.1163/
156856207779996931.
2 X. Liu, M. N. George, S. Park, A. L. Miller II, B. Gaihre, L. Li
and L. Lu, 3D-printed scaffolds with carbon nanotubes for
bone tissue engineering: Fast and homogeneous one-step
functionalization, Acta Biomater., 2020, 111, 129–140, DOI:
10.1016/j.actbio.2020.04.047.
3 R. Yang, S. Yang, K. Li, Z. Luo, B. Xian, J. Tang and J. Ge,
Carbon Nanotube Polymer Scaffolds as a Conductive
Alternative for the Construction of Retinal Sheet Tissue,
ACS Chem. Neurosci., 2021, 12, 3167–3175, DOI: 10.1021/
acschemneuro.1c00242.
4 A. F. Girao, J. Sousa, A. Dominguez-Bajo, A. Gonzalez-
Mayorga, I. Bdikin, E. Pujades-Otero and P. A. Marques, 3D
Reduced Graphene Oxide Scaffolds with a Combinatorial
Fibrous-Porous Architecture for Neural Tissue Engineering,
ACS Appl. Mater. Interfaces, 2020, 12, 38962–38975, DOI:
10.1021/acsami.0c10599.
5 Z. Li, S. Xiang, Z. Lin, E. N. Li, H. Yagi, G. Cao and H. Lin,
Graphene oxide-functionalized nanocomposites promote
osteogenesis of human mesenchymal stem cells via
enhancement of BMP-SMAD1/5 signaling pathway,
Biomaterials, 2021, 121082, DOI: 10.1016/
j.biomaterials.2021.121082.
6 S. S. Suner, S. Demirci, B. Yetiskin, R. Fakhrullin,
E. Naumenko, O. Okay and N. Sahiner, Cryogel composites
based on hyaluronic acid and halloysite nanotubes as
scaffold for tissue engineering, Int. J. Biol. Macromol., 2019,
130, 627–635, DOI: 10.1016/j.ijbiomac.2019.03.025.
7 E. Naumenko and R. Fakhrullin, Halloysite nanoclay/
biopolymers composite materials in tissue engineering,
Biotechnol. J., 2019, 14, 1900055, DOI: 10.1002/
biot.201900055.
8 E. A. Naumenko, I. D. Guryanov, R. Yendluri, Y. M. Lvov and
R. F. Fakhrullin, Clay nanotube–biopolymer composite
scaffolds for tissue engineering, Nanoscale, 2016, 8, 7257–
7271, DOI: 10.1039/C6NR00641H.
9 Z. P. Xu, G. S. Stevenson, C. Q. Lu, G. Q. Lu, P. F. Bartlett and
P. P. Gray, Stable suspension of layered double hydroxide
nanoparticles in aqueous solution, J. Am. Chem. Soc., 2006,
128, 36–37, DOI: 10.1021/ja056652a.
10 J. Nath, A. Ahmed, P. Saikia, A. Chowdhury and S. K. Dolui,
Acrylic acid graed gelatin/LDH based biocompatible
hydrogel with the pH-controllable release of vitamin B12,
Appl. Clay Sci., 2020, 190, 105569, DOI: 10.1016/
j.clay.2020.105569.
11 J. H. Lee, W. Zhang, H. J. Ryu, G. Choi, J. Y. Choi and
J. H. Choy, Enhanced thermal stability and mechanical
property of EVA nanocomposites upon addition of organo-
intercalated LDH nanoparticles, Polymer, 2019, 117, 274–
281, DOI: 10.1016/j.polymer.2019.06.011.
12 M. Shamsayei, Y. Yamini, H. Asiabi and M. Safari, On-line
packed magnetic in-tube solid-phase microextraction of
acidic drugs naproxen and indomethacin by using
Fe3O4@SiO2@layered double hydroxide nanoparticles
with high anion exchange capacity, Microchim. Acta, 2018,
185, 192, DOI: 10.1007/s00604-018-2716-7.
13 L. Yan, W. Chen, X. Zhu, L. Huang, G. Zhu, Z. Wang,
V. A. L. Roy, X. Chen and X. Chen, Folic acid conjugated
self-assembled layered double hydroxide nanoparticles for
high-efficacy-targeted drug delivery, Chem. Commun., 2013,
49, 10938–10940, DOI: 10.1039/c3cc45714a.
14 S. Dasgupta, Controlled release of ibuprofen using Mg-Al
LDH nano carrier, IOP Conf. Ser.: Mater. Sci. Eng., 2017,
225, 012005, DOI: 10.1088/1757-899X/225/1/012005.
15 C. da Costa Fernandes, T. S. Pinto, H. R. Kang, P. de
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